Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental model systems to study vascular aging.

Ageing research reviews·2026
Same author

Corrigendum to: Refining quality control strategies in highly automated laboratories: experience in the integration of multistage statistical designs and risk management.

Biochemia medica·2026
Same author

Niacin Derivatives in MASLD: Metabolic and Therapeutic Insights.

Nutrients·2026
Same author

Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal study.

Cardiovascular diabetology·2026
Same author

Targeting Atherosclerosis: Cholesterol-Lowering Therapies with a New Immunometabolic Dress for an Old Disease.

Journal of clinical medicine·2025
Same author

Association between dietary niacin intake and diabetic retinopathy in a Catalonian population: a cross-sectional study.

Frontiers in nutrition·2025

Related Experiment Video

Updated: Jun 15, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary

Jesús Méndez-González1, Elisabeth Rodríguez-Millán, Josep Julve

  • 1Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Espana.

Revista De Neurologia
|March 4, 2010
PubMed
Summary

High homocysteine (Hcy) levels increase vascular disease risk. While vitamin therapy lowers Hcy, it did not reduce cardiovascular risk but shows promise for primary stroke prevention.

Related Experiment Videos

Last Updated: Jun 15, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Neurology

Context:

  • Elevated plasma homocysteine (Hcy) is linked to increased vascular disease risk.
  • Previous trials investigated vitamin therapies for secondary prevention of cardiovascular and cerebrovascular diseases.

Purpose:

  • To evaluate the efficacy of vitamin therapies in reducing cardiovascular and cerebrovascular disease risk.
  • To assess the impact of homocysteine-lowering treatments on stroke prevention.

Summary:

  • Large randomized trials demonstrated that vitamin therapy effectively reduces plasma Hcy concentrations.
  • These therapies failed to decrease secondary cardiovascular disease risk.
  • Recent meta-analyses suggest a potential benefit for primary stroke prevention, aligning with Hcy's stronger association with stroke risk.

Impact:

  • Findings suggest a potential role for Hcy intervention in primary stroke prevention, warranting further investigation.
  • This research may influence future strategies for managing vascular and cerebrovascular health.
  • The results highlight the nuanced relationship between Hcy levels and different vascular outcomes.